What the newly released Medicare prices for 10 drugs do and don’t tell us

16 August 2024 - CMS needs to beware of unintended consequences that might hamper patient access. ...

Read more →

Medicare’s drug price talks are about to get more heated

16 August 2024 - Drug makers and officials are fighting over many aspects of the now-annual negotiations. ...

Read more →

Commemorating the second anniversary of the Biden-Harris Lower Cost Prescription Drug Law

16 August 2024 - The Inflation Reduction Act is saving Americans millions in lower prescription drug costs and making health ...

Read more →

Negotiating for lower drug prices works, saves billions

15 August 2024 - In a historic moment that will help lower prescription drug prices for millions of people across America, ...

Read more →

How to tell if Biden drove a hard bargain in Medicare drug price negotiations

30 July 2024 - The deadline for announcing how much Medicare lowered drug prices in the first year of negotiation is ...

Read more →

Novo Nordisk latest drugmaker to face setback in IRA litigation

1 August 2024 - A federal court backed the Biden administration’s Medicare drug price negotiation program on Wednesday, the latest ...

Read more →

Drug middlemen push patients to pricier medicines, House probe finds

23 July 2024 - Findings from the House Oversight investigation add to criticism that pharmacy-benefit managers are driving up drug spending. ...

Read more →

Johnson & Johnson, BMS fight US drug price plan at Third Circuit

16 July 2024 - Pharmaceutical giants Johnson & Johnson, BMS and AstraZeneca are rejecting federal district court decisions that rule ...

Read more →

FTC to sue drug managers over insulin prices

10 July 2024 - Antitrust agency is investigating how PBMs and manufacturers negotiate discounts. ...

Read more →

Pharmacy middlemen appear to be inflating drug prices, FTC says

9 July 2024 - The Federal Trade Commission released a critical report detailing how pharmacy benefit managers—like CVS Health’s Caremark, Cigna’s ...

Read more →

Judge rules against Boehringer Ingelheim in pharma’s latest legal loss on Medicare negotiation

5 July 2024 - A federal judge ruled against Boehringer Ingelheim’s challenge to the new Medicare drug price negotiation program, ...

Read more →

President Biden: Novo Nordisk, Eli Lilly must stop ripping off Americans with high drug prices

2 July 2024 - If Novo Nordisk and other pharmaceutical companies refuse to substantially lower prescription drug prices in our country ...

Read more →

HHS announces cost savings for 64 prescription drugs thanks to the Medicare Rebate Program established by the Biden-Harris Administration’s Lower Cost Prescription Drug Law

26 June 2024 - Under President Biden’s Inflation Reduction Act, some people with Medicare will pay less for some Part ...

Read more →

The opaque industry secretly inflating prices for prescription drugs

21 June 2024 - Pharmacy benefit managers are driving up drug costs for millions of people, employers and Government. ...

Read more →

ICER publishes protocol for annual assessment of drug coverage policies that present barriers to fair access

5 June 2024 - This year’s analysis will include the top ten commercial formularies by covered lives, and include drugs ...

Read more →